Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.

Rosenzwajg, Michelle; Lorenzon, Roberta; Cacoub, Patrice; Pham, Hang Phuong; Pitoiset, Fabien; El Soufi, Karim; RIbet, Claire; Bernard, Claude; Aractingi, Selim; Banneville, Beatrice; Beaugerie, Laurent; Berenbaum, Francis; Champey, Julien; Chazouilleres, Olivier; Corpechot, Christophe; Fautrel, Bruno; Mekinian, Arsène; Regnier, Elodie; Saadoun, David; Salem, Joe-Elie; Sellam, Jérémie; Seksik, Philippe; Daguenel-Nguyen, Anne; Doppler, Valérie; Mariau, Jéremie; Vicaut, Eric; Klatzmann, David.
Ann Rheum Dis; 78(2): 209-217, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30472651